Abstract 63P
Background
Colorectal cancer is one of the most common cancers in our country. Different clinicopathological features and outcome have been demonstrated between right and left CRC. In our study, we aim to characterize tumor sidedness, clinical profile and histological features of colorectal cancer to improve oncological care.
Methods
The data was retrospectively taken from Medical Oncology OPD Registry, YGH, over one year period from January, 2020 to December, 2020. Summary statistics were used to describe results.
Results
Total 225 (63 right side and 162 left side) patients were included in this study. Right sided tumor included from caecum to splenic flexure. Left sided one represented the remaining large bowel including rectum. The sites observed were caecum (6.6%), ascending colon (9.3%), hepatic flexure (6.6%), transverse colon (3.5%), splenic flexure (1.7%), descending colon (5.7%), sigmoid colon (7.5%), recto-sigmoid (12%) and rectum (46%) respectively. Mean age was 52 years, the youngest was 14 years and the oldest was 89 years. Forty percents of patients were <50 years of age. In right side, male patients (52%) were more than female patients (48%). In left side, slight female preponderance over male (51% Vs 49%) was seen. Presentation with intestinal obstruction or perforation was more commonly seen in right side (38%) than left side (22%). The most common histological subtype in both sides was moderately differentiated adenocarcinoma. Special subtype (mucinous and signet ring cell type) was more commonly seen in right side (24%) than left side (10.5%). More than 80% of patients came with advanced stage (stage III and IV) in both sides. The most common site of metastasis from both sides was peritoneum and liver.
Conclusions
In this study, there were more patients with left-sided CRC than right-sided. And like other countries, the burden of disease in younger patients is quite concerning. As most patients were diagnosed at advanced stage, necessary interventions for CRC awareness should be promoted. This study also highlights that clinicopathological differences exist between right and left colorectal cancer, possibly indicating prognostic significance that might improve the oncological care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
57P - V-set and immunoglobulin domain containing 1 (VSIG1): Gene vs protein expression in colorectal cancer tissue samples
Presenter: Simona Gurzu
Session: Poster viewing 02
58P - Clinicopathologic profile and outcomes of rectal cancer (RC) in the young (<50 years old): A single institution experience
Presenter: Fatma Amina Hussin Ibrahim
Session: Poster viewing 02
59P - Platelet-derived growth factor (PDGF)-CC serum as clinical outcome predictor after six cycles of chemotherapy in colorectal cancer at RSMH Palembang
Presenter: Erty Sundarita
Session: Poster viewing 02
60P - Predictors of survival in stage III colorectal cancer patients treated with surgery and adjuvant chemotherapy: A single institution observational study
Presenter: Keng Man Chiang
Session: Poster viewing 02
61P - Can total neoadjuvant therapy in locally advanced rectal cancer replace standard treatment protocol?
Presenter: Ankita Mallick
Session: Poster viewing 02
62P - Chief complaints and baseline clinicopathological features of patients with colorectal cancer in a tertiary hospital in Yogyakarta Indonesia
Presenter: Yasjudan Putra
Session: Poster viewing 02
64P - Clinical profile and treatment outcome of patients with non-metastatic colon cancer: A single institutional study from India
Presenter: Sandip Ganguly
Session: Poster viewing 02
65P - Comparison of survival and recurrence pattern in Thai early stage colorectal cancer patients by tumor sidedness
Presenter: Chanchai Charonpongsuntorn
Session: Poster viewing 02
77P - Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for gastric cancer: The FUGES-012 randomized clinical trial
Presenter: Qing Zhong
Session: Poster viewing 02